iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
Recruiting · NCT03608631 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic ductal adenocarcinoma, pancreatic neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-09-04 | NCT03608631 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| M.D. Anderson Cancer Center | 1145 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| M D Anderson Cancer Center | Houston | United States | 667 |